Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
"Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of G-protein-coupled receptors that share significant homology with GLUCAGON RECEPTORS. They bind PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE with high affinity and trigger intracellular changes that influence the behavior of CELLS.
Concept/Terms
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide- Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
- Receptors, Pituitary Adenylate Cyclase Activating Polypeptide
- Receptor, PACAP
- Pituitary Adenylate Cyclase-Activating Peptide Receptor
- Pituitary Adenylate Cyclase Activating Peptide Receptor
- Pituitary Adenylate Cyclase-Activating Peptide Receptors
- Pituitary Adenylate Cyclase Activating Peptide Receptors
- PACAP Receptor
- PACAP Receptors
- Receptors, PACAP
Below are MeSH descriptors whose meaning is more general than "Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide".
This graph shows the total number of publications written about "Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 3 | 3 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
Below are the most recent publications written about "Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide" by people in Profiles.
-
Pair bond formation is impaired by VPAC receptor antagonism in the socially monogamous zebra finch. Behav Brain Res. 2014 Oct 01; 272:264-8.
-
Activation of PAC(1) and VPAC receptor subtypes elicits differential physiological responses from sympathetic preganglionic neurons in the anaesthetized rat. Br J Pharmacol. 2012 Nov; 167(5):1089-98.
-
Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) on IL-6, IL-8, and MCP-1 expression in human retinal pigment epithelial cell line. Curr Eye Res. 2005 Dec; 30(12):1105-11.
-
Expression of vasoactive intestinal peptide and functional VIP receptors in human prostate cancer: antagonistic action of a growth-hormone-releasing hormone analog. Int J Oncol. 2005 Jun; 26(6):1629-35.
-
Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue. Gynecol Endocrinol. 2005 Jun; 20(6):327-33.
-
Differential coupling of the PAC1 SV1 splice variant on human colonic tumors to the activation of intracellular cAMP but not intracellular Ca2+ does not activate tumor proliferation. J Mol Neurosci. 2004; 22(1-2):83-92.
-
Expression of functional PACAP/VIP receptors in human prostate cancer and healthy tissue. Peptides. 2003 Jun; 24(6):893-902.
-
VIP and PACAP receptors coupled to adenylyl cyclase in human lung cancer: a study in biopsy specimens. Peptides. 2003 Mar; 24(3):429-36.
-
Maxadilan activates PAC1 receptors expressed in Xenopus laevis xelanophores. Pigment Cell Res. 2002 Dec; 15(6):461-6.
-
Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors. Cell Signal. 2001 Dec; 13(12):887-94.